Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 4, 2009, Pages 1083-1090

  Yin, Hui Nan ^a   Chai, Jia Ke ^a   Yu, Yong Ming ^a,b   Shen, Chuan An ^a   Wu, Yan Qiu ^a   Yao, Yong Ming ^a,b   Liu, Hui ^a   Liang, Li Ming ^a   Tompkins, Ronald G ^b   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Glycogen synthase kinase 3 (GSK 3 ); Muscle atrophy F box (MAFbx); Muscle RING finger 1 (MuRF1); p70 Ribosomal protein S6 kinase (p70S6K); Protein kinase B (Akt)

Indexed keywords

ATROGIN 1; DEXAMETHASONE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; MUSCLE RING FINGER 1 PROTEIN; PROTEIN KINASE B; S6 KINASE; SOMATOMEDIN C; TESTOSTERONE; UBIQUITIN PROTEIN LIGASE E3; ANDROGEN; FBXO32 PROTEIN, RAT; GLUCOCORTICOID; MUSCLE PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME PHOSPHORYLATION; FEMALE; GASTROCNEMIUS MUSCLE; HORMONAL REGULATION; HORMONE SYNTHESIS; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANDROGENS; ANIMALS; BODY WEIGHT; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; INSULIN-LIKE GROWTH FACTOR I; MUSCLE PROTEINS; MUSCLE, SKELETAL; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; TESTOSTERONE;

EID: 67651031264     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31817e7420     Document Type: Article

References (45)

1. Tiao G, Fagan J, Roegner V, et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest. 1996;97:339-348. (Pubitemid 26039396)
2. Fang CH, James HJ, Ogle C, Fischer JE, Hasselgren PO. Influence of burn injury on protein metabolism in different types of skeletal muscle and the role of glucocorticoids. J Am Coll Surg. 1995;180:33-42.
3. Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab. 2003;88:3167-3176.
4. Creutzberg EC, Schols AM. Anabolic steroids. Curr Opin Clin Nutr Metab Care. 1999;2:243-253.
5. Creutzberg EC, Wouters EF, Mostert R, Pluymers RJ, Schols AM. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest. 2003;124:1733-1742. (Pubitemid 37433566)
6. Vary TC. IGF-I stimulates protein synthesis in skeletal muscle through multiple signaling pathways during sepsis. Am J Physiol Regul Integr Comp Physiol. 2006;290:R313-R321.
7. Lang CH, Frost RA, Vary TC. Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab. 2007;293:E453-E459. (Pubitemid 47205087)
8. Gayan-Ramirez G, Vanderhoydonc F, Verhoeven G, Decramer M. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med. 1999;159:283-289. (Pubitemid 29036536)
9. Kamanga-Sollo E, Pampusch MS, Xi G, White ME, Hathaway MR, Dayton WR. IGF-I mRNA levels in bovine satellite cell cultures: effects of fusion and anabolic steroid treatment. J Cell Physiol. 2004;201:181-189. (Pubitemid 39305096)
10. Lewis MI, Horvitz GD, Clemmons DR, Fournier M. Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone. Am J Physiol Endocrinol Metab. 2002;282:E483-E490. (Pubitemid 34654820)
11. Gayan-Ramirez G, Rollier H, Vanderhoydonc F, Verhoeven G, Gosselink R, Decramer M. Nandrolone decanoate does not enhance training effects but increases IGF-I mRNA in rat diaphragm. J Appl Physiol. 2000;88:26-34. (Pubitemid 30053823)
12. Xu T, Shen Y, Pink H, et al. Phosphorylation of p70s6 kinase is implicated in androgen-induced levator ani muscle anabolism in castrated rats. J Steroid Biochem Mol Biol. 2004;92:447-454. (Pubitemid 40192528)
13. Eason JM, Dodd SL, Powers SK. Use of anabolic steroids to attenuate the effects of glucocorticoids on the rat diaphragm. Phys Ther. 2003;83:29-36.
14. Konno S. Hydroxyl radical formation in skeletal muscle of rats with glucocorticoid-induced myopathy. Neurochem Res. 2005;30:669-675. (Pubitemid 41185884)
15. Ma K, Mallidis C, Bhasin S, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 2003;285:E363-E371. (Pubitemid 36899710)
16. Fletcher LK, Powers SK, Coombes JS, et al. Glucocorticoid-induced alterations in the rate of diaphragmatic fatigue. Pharmacol Res. 2000;42:61-68.
17. Dodd SL, Powers SK, Vrabas IS, Eason JM. Interaction of glucocorticoids and activity patterns affect muscle function. Muscle Nerve. 1995;18:190-195.
18. Fang CH, Li BG, Tiao G, Wang JJ, Fischer JE, Hasselgren PO. The molecular regulation of protein breakdown following burn injury is different in fast- and slow-twitch skeletal muscle. Int J Mol Med. 1998;1:163-169.
19. Roy RR, Gardiner PF, Simpson DR, Edgerton VR. Glucocorticoid-induced atrophy in different fibre types of selected rat jaw and hindlimb muscles. Arch Oral Biol. 1983;28:639-643.
20. Tiao G, Lieberman M, Fischer JE, Hasselgren PO. Intracellular regulation of protein degradation during sepsis is different in fast-and slow-twitch muscle. Am J Physiol. 1997;272:R849-R856. (Pubitemid 27146792)
21. Dumas JF, Simard G, Roussel D, et al. Mitochondrial energy metabolism in a model of undernutrition induced by dexamethasone. Br J Nutr. 2003;90:969-977. (Pubitemid 37328071)
22. Lewis MI, Monn SA, Sieck GC. Effect of corticosteroids on diaphragm fatigue, SDH activity, and muscle fiber size. J Appl Physiol. 1992;72:293-301.
23. Dekhuijzen PN, Gayan-Ramirez G, Bisschop A, De Bock V, Dom R, Decramer M. Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J Appl Physiol. 1995;78:629-637.
24. Van Balkom RH, Zhan WZ, Prakash YS, Dekhuijzen PN, Sieck GC. Corticosteroid effects on isotonic contractile properties of rat diaphragm muscle. J Appl Physiol. 1997;83:1062-1067. (Pubitemid 27433070)
25. Adams GR. Autocrine/paracrine IGF-I and skeletal muscle adaptation. J Appl Physiol. 2002;93:1159-1167.
26. Hardt SE, Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res. 2002;90:1055-1063. (Pubitemid 34627903)
27. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785-789. (Pubitemid 26004411)
28. Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001;3:1009-1013. (Pubitemid 34428746)
29. Evenson AR, Fareed MU, Menconi MJ, Mitchell JC, Hasselgren PO. GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes. Int J Biochem Cell Biol. 2005;37:2226-2238.
30. Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW. GSK-3beta negatively regulates skeletal myotube hypertrophy. Am J Physiol Cell Physiol. 2002;283:C545-C551.
31. Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol. 2005;3:209-217. (Pubitemid 40852404)
32. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294:1704-1708. (Pubitemid 33104839)
33. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A. 2001;98:14440-14445. (Pubitemid 33121410)
34. Cao PR, Kim HJ, Lecker SH. Ubiquitin-protein ligases in muscle wasting. Int J Biochem Cell Biol. 2005;37:2088-2097.
35. Leger B, Vergani L, Soraru G, et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20:583-585. (Pubitemid 46671257)
36. Dehoux M, Van Beneden R, Pasko N, et al. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes. Endocrinology. 2004;145:4806-4812. (Pubitemid 39551094)
37. Dehoux MJ, van Beneden RP, Fernandez-Celemin L, Lause PL, Thissen JP. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett. 2003;544:214-217. (Pubitemid 36628065)
38. Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol. 2004;15:1537-1545. (Pubitemid 38679678)
39. DeRuisseau KC, Kavazis AN, Deering MA, et al. Mechanical ventilation induces alterations of the ubiquitin-proteasome pathway in the diaphragm. J Appl Physiol. 2005;98:1314-1321.
40. Latres E, Amini AR, Amini AA, et al. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem. 2005;280:2737-2744. (Pubitemid 40189380)
41. Li YP, Chen Y, Li AS, Reid MB. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol. 2003;285:C806-C812. (Pubitemid 37158805)
42. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117:399-412. (Pubitemid 38534545)
43. Stitt TN, Drujan D, Clarke BA, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell. 2004;14:395-403. (Pubitemid 38591410)
44. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab. 2004;287:E591-E601. (Pubitemid 39242684)
45. Wolf SE, Edelman LS, Kemalyan N, et al. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res. 2006;27:131-139. (Pubitemid 43970312)